Clinical Trial Update: Effect of Low-Dose Baclofen Administration on the GH-IGF1 Axis Study [NA]

View source ↗

Summary

An update on a completed clinical trial assessing the effect of low-dose baclofen on the growth hormone–IGF-1 axis in individuals with spinal cord injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• LIORESAL (BACLOFEN)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Spinal Cord Injury | NA | Status: COMPLETED